Keywords: lilly, wins, backing, long-term, zyprexa, eli, won

Lilly wins US backing for long-term Zyprexa

Article | 15 November 2000

Print This

Eli Lilly has won US Food and Drug Administration approval to market itsantipsychotic drug Zyprexa (olanzapine) for an additional indication, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in